HomeKREBSBIO • NSE
add
Krebs Biochemicals And Industries Ltd
Nakaraang pagsara
₹125.30
Sakop ng araw
₹112.77 - ₹123.83
Sakop ng taon
₹60.35 - ₹129.07
Market cap
1.90B INR
Average na Volume
46.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
Mga balita tungkol sa merkado
MarketWatch
1 araw ang nakalipas
Wall Street sees ‘no alternative’ to U.S. stocks in 2025. Here’s why.
0.072%
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 128.55M | -13.67% |
Gastos sa pagpapatakbo | 147.70M | -3.30% |
Net na kita | -57.61M | -61.31% |
Net profit margin | -44.81 | -86.86% |
Kita sa bawat share | — | — |
EBITDA | -26.35M | -248.92% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.44M | 84.16% |
Kabuuang asset | 1.85B | 3.97% |
Kabuuang sagutin | 3.15B | 10.07% |
Kabuuang equity | -1.30B | — |
Natitirang share | 21.58M | — |
Presyo para makapag-book | -2.08 | — |
Return on assets | — | — |
Return on capital | -14.59% | — |
Cash Flow
Net change in cash
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -57.61M | -61.31% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Itinatag
1991
Website
Mga Empleyado
191
